DiaMedica Therapeutics Stock Forecast - 8 Period Moving Average

DMAC Stock  USD 4.34  0.05  1.17%   
The 8 Period Moving Average forecasted value of DiaMedica Therapeutics on the next trading day is expected to be 4.37 with a mean absolute deviation of 0.16 and the sum of the absolute errors of 8.51. DiaMedica Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast DiaMedica Therapeutics stock prices and determine the direction of DiaMedica Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of DiaMedica Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At present, DiaMedica Therapeutics' Fixed Asset Turnover is projected to increase slightly based on the last few years of reporting. . The current year's Common Stock Shares Outstanding is expected to grow to about 34.2 M, whereas Net Loss is projected to grow to (11.6 M).
Most investors in DiaMedica Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the DiaMedica Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets DiaMedica Therapeutics' price structures and extracts relationships that further increase the accuracy of the generated results. An 8-period moving average forecast model for DiaMedica Therapeutics is based on an artificially constructed time series of DiaMedica Therapeutics daily prices in which the value for a trading day is replaced by the mean of that value and the values for 8 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

DiaMedica Therapeutics 8 Period Moving Average Price Forecast For the 21st of October

Given 90 days horizon, the 8 Period Moving Average forecasted value of DiaMedica Therapeutics on the next trading day is expected to be 4.37 with a mean absolute deviation of 0.16, mean absolute percentage error of 0.04, and the sum of the absolute errors of 8.51.
Please note that although there have been many attempts to predict DiaMedica Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that DiaMedica Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

DiaMedica Therapeutics Stock Forecast Pattern

Backtest DiaMedica TherapeuticsDiaMedica Therapeutics Price PredictionBuy or Sell Advice 

DiaMedica Therapeutics Forecasted Value

In the context of forecasting DiaMedica Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. DiaMedica Therapeutics' downside and upside margins for the forecasting period are 1.12 and 7.62, respectively. We have considered DiaMedica Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
4.34
4.37
Expected Value
7.62
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 8 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of DiaMedica Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent DiaMedica Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria100.1206
BiasArithmetic mean of the errors -0.0797
MADMean absolute deviation0.1605
MAPEMean absolute percentage error0.0394
SAESum of the absolute errors8.5062
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. DiaMedica Therapeutics 8-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for DiaMedica Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as DiaMedica Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DiaMedica Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
1.184.437.68
Details
Intrinsic
Valuation
LowRealHigh
1.885.138.38
Details
4 Analysts
Consensus
LowTargetHigh
7.588.339.25
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as DiaMedica Therapeutics. Your research has to be compared to or analyzed against DiaMedica Therapeutics' peers to derive any actionable benefits. When done correctly, DiaMedica Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in DiaMedica Therapeutics.

Other Forecasting Options for DiaMedica Therapeutics

For every potential investor in DiaMedica, whether a beginner or expert, DiaMedica Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. DiaMedica Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in DiaMedica. Basic forecasting techniques help filter out the noise by identifying DiaMedica Therapeutics' price trends.

DiaMedica Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with DiaMedica Therapeutics stock to make a market-neutral strategy. Peer analysis of DiaMedica Therapeutics could also be used in its relative valuation, which is a method of valuing DiaMedica Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

DiaMedica Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of DiaMedica Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of DiaMedica Therapeutics' current price.

DiaMedica Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how DiaMedica Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DiaMedica Therapeutics shares will generate the highest return on investment. By undertsting and applying DiaMedica Therapeutics stock market strength indicators, traders can identify DiaMedica Therapeutics entry and exit signals to maximize returns.

DiaMedica Therapeutics Risk Indicators

The analysis of DiaMedica Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in DiaMedica Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting diamedica stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether DiaMedica Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DiaMedica Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Diamedica Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Diamedica Therapeutics Stock:
Check out Historical Fundamental Analysis of DiaMedica Therapeutics to cross-verify your projections.
For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DiaMedica Therapeutics. If investors know DiaMedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DiaMedica Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.51)
Return On Assets
(0.24)
Return On Equity
(0.35)
The market value of DiaMedica Therapeutics is measured differently than its book value, which is the value of DiaMedica that is recorded on the company's balance sheet. Investors also form their own opinion of DiaMedica Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is DiaMedica Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DiaMedica Therapeutics' market value can be influenced by many factors that don't directly affect DiaMedica Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DiaMedica Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DiaMedica Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DiaMedica Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.